Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · IEX Real-Time Price · USD
0.158
-0.009 (-5.45%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $7.73 million as of April 25, 2024. Its market cap has decreased by -92.38% in one year.
Market Cap
7.73M
Enterprise Value
13.02M
1-Year Change
-92.38%
Ranking
Category
Stock Price
$0.16
Market Cap Chart
Since September 10, 2021, Calidi Biotherapeutics's market cap has decreased from $248.50M to $7.73M, a decrease of -96.89%. That is a compound annual growth rate of -73.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 5.90M | 7.27% |
Apr 22, 2024 | 5.50M | -5.17% |
Apr 19, 2024 | 5.80M | 1.75% |
Apr 18, 2024 | 5.70M | -17.39% |
Apr 17, 2024 | 6.90M | -6.76% |
Apr 16, 2024 | 7.40M | -65.26% |
Apr 15, 2024 | 21.30M | -13.77% |
Apr 12, 2024 | 24.70M | 8.81% |
Apr 11, 2024 | 22.70M | 8.61% |
Apr 10, 2024 | 20.90M | -4.57% |
Apr 9, 2024 | 21.90M | 62.22% |
Apr 8, 2024 | 13.50M | -4.26% |
Apr 5, 2024 | 14.10M | -6.62% |
Apr 4, 2024 | 15.10M | -13.22% |
Apr 3, 2024 | 17.40M | -1.69% |
Apr 2, 2024 | 17.70M | -10.15% |
Apr 1, 2024 | 19.70M | -1.99% |
Mar 28, 2024 | 20.10M | -0.50% |
Mar 27, 2024 | 20.20M | -0.49% |
Mar 26, 2024 | 20.30M | -2.40% |
Mar 25, 2024 | 20.80M | 0.97% |
Mar 22, 2024 | 20.60M | -3.74% |
Mar 21, 2024 | 21.40M | -7.76% |
Mar 20, 2024 | 23.20M | 6.42% |
Mar 19, 2024 | 21.80M | 2.35% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Longeveron | 8.73M |
Precipio | 8.44M |
Molecular Templates | 8.33M |
Virios Therapeutics | 8.30M |
Cyclerion Therapeutics | 8.27M |
Hepion Pharmaceuticals | 8.15M |
Universe Pharmaceuticals INC | 8.02M |
Akari Therapeutics, | 8.01M |